Evidence map›Paper›PMID 32722166›Full record

ArticleInternational journal of molecular sciences2020

Exploring IDP-Ligand Interactions: tau K18 as A Test Case.

Darius Vagrys, James Davidson, Ijen Chen, Roderick E Hubbard, Ben Davis

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Darius VagrysVernalis Research, Granta Park, Great Abington, Cambridge CB21 6GB, UK.ORCID 0000-0002-8988-9787
James DavidsonVernalis Research, Granta Park, Great Abington, Cambridge CB21 6GB, UK.
Ijen ChenVernalis Research, Granta Park, Great Abington, Cambridge CB21 6GB, UK.ORCID 0000-0001-8865-3193
Roderick E HubbardVernalis Research, Granta Park, Great Abington, Cambridge CB21 6GB, UK.ORCID 0000-0002-8233-7461
Ben DavisVernalis Research, Granta Park, Great Abington, Cambridge CB21 6GB, UK.ORCID 0000-0001-6759-7575
Granta Design (United Kingdom) · GB

Funding

H2020 Marie Skłodowska-Curie Actions 675899
6 · The paper itself

Abstract

Over the past decade intrinsically disordered proteins (IDPs) have emerged as a biologically important class of proteins, many of which are of therapeutic relevance. Here, we investigated the interactions between a model IDP system, tau K18, and nine literature compounds that have been reported as having an effect on tau in order to identify a robust IDP-ligand system for the optimization of a range of biophysical methods. We used NMR, surface plasmon resonance (SPR) and microscale thermophoresis (MST) methods to investigate the binding of these compounds to tau K18; only one showed unambiguous interaction with tau K18. Several near neighbors of this compound were synthesized and their interactions with tau K18 characterized using additional NMR methods, including 1D ligand-observed NMR, diffusion-ordered spectroscopy (DOSY) and

Indexed as

Molecular Docking SimulationHumansIntrinsically Disordered ProteinsLigandsNuclear Magnetic Resonance, Biomoleculartau ProteinsIntrinsically Disordered ProteinsLigandsMAPT protein, humantau Proteinsintrinsically disordered proteinmicroscale thermophoresisnuclear magnetic resonancesurface plasmon resonancetau K18

Identifiers

PMID32722166
PMCPMC7432903
OpenAlexW3045235441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.